Cardiomyopathy Trial, Recruiting NCT06978998 Sponsor: Yonsei University Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06978998
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 20 and 79 years old whose heart is pumping less efficiently than normal (the heart pumps out 40% or less of its blood with each beat, as measured by an ultrasound of the heart), and who are able to give written agreement to take part in the study voluntarily.

Who may not be able to join:

  • People whose eye conditions are too severe to allow a clear photograph of the back of the eye to be taken.
  • People who have widespread disease affecting the retina (the light-sensitive layer at the back of the eye) that makes it too difficult to see the blood vessels there clearly.
  • People who do not wish to give their written agreement to take part in the study.
  • People who are pregnant.
  • People who do not have the ability to make their own decisions about taking part (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 December 2024
Est. completion
10 December 2030

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Occurrence of adjudicated cardiovascular event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov